51³ΙΘΛΆ―Βώ

Meeting Coverage

ACR Video Pearls

Video Pearls from the American College of Rheumatology

Clinical Outcomes Worse for Systemic Sclerosis Patients With PAH Plus ILD

Study turns up a significant survival difference

image

Latest ACR Video Pearls Meeting Coverage

Early ACE Inhibitor Use for Scleroderma Renal Crisis Not Tied to Lower Mortality

Initiation within 48 hours was associated with reduced need for dialysis, however

December 5, 2022
Risk Stratification in Systemic Sclerosis-Associated PAH

Using EUSTAR data, researchers sought to identify the best risk assessment approach

November 28, 2022
TNF Receptor 1 May Drive Pulmonary Arterial Hypertension Phenotype

Study further evaluated endothelial and stromal cell alterations in TNF-transgenic mice lungs

November 21, 2022
Real-World Treatment Preferences of Patients With Psoriatic Arthritis

Olga Petryna, MD, explains the recent shift in medication patterns

December 14, 2021
Secukinumab and CV Safety in Psoriasis, PsA, and Axial Spondyloarthritis

Sheila Reyes, MD, reviews results from post hoc analysis

December 7, 2021
Guselkumab vs Ustekinumab in Psoriatic Arthritis

Study results not surprising, but always better to have comparison data

November 30, 2021
Secukinumab Reduces Flare Risk in Juvenile PsA and ERA

Eric Ruderman, MD, discusses the JUNIPERA study

November 23, 2021
Anti-NGF Therapy for OA Pain: Study Raises New Questions

Joint safety continues to be a concern for tanezumab

January 6, 2020
Hydroxychloroquine Lowers CV Risk in RA

Study finds 53% lower risk of major adverse cardiovascular events in elderly patients with rheumatoid arthritis

December 2, 2019
Methotrexate Increases Risk of 'Many Adverse Events'

While they may be rare, Daniel Solomon says, rheumatologists need to be watchful

November 18, 2019

Videos

ACR
November 2024
EULAR
June 2024